Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$19→HK$19.5 | ― | 10.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$4→HK$4.2 | ― | 15.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$43.9 | ― | 2.60% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$17.2 | ― | 9.90% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$75.37 | ― | 3.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$73→HK$75 | ― | 16.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$63→HK$67 | ― | 2.90% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$21.5→HK$18.4 | ― | 11.50% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$100→HK$120 | ― | 15.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$55 | ― | 15.70% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$4.7→HK$4.8 | ― | 3.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$4.1 | ― | 27.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$62.66→HK$117.81 | ― | 34.30% | Upgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$100 | ― | 13.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$17 | ― | 28.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$22.19 | ― | 17.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$20.2→HK$20.1 | ― | 27.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$14 | ― | 32.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$61.9 | ― | 2.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$17.02→HK$15.88 | ― | 2.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$58→HK$64 | ― | 3.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$62 | ― | 13.00% | Reiterated | ||||
| Vesync Co., Ltd. | BUY HK$6.79 | ― | -4.10% | Reiterated | We expect the GP margin to be stable at 45%-46% in FY24E (a drop from 46.9% in FY23), as favorable factors like the depreciation of RMB will ease while the freight rate may increase mildly due to Red Sea conflicts. For NP margin, we believe it can be at around 13.5% (from 13.2% in FY23), as the operating leverage will offset the headwind in GP margin and the small increase in A&P expenses. Maintain BUY and fine-tune TP to HK$6.79. Considering the robust growth (13% sales and 16% net profit CAGR during FY23-26E), we believe its current valuation of 7x is still highly attractive. Our TP is based on 11x FY24E P/E (rolled over from 14x FY23E P/E, vs 3-year average of 12x). | |||
| Aluminum of China | BUY HK$6.1 | ― | -23.50% | Reiterated | Buy Rating Affirmed for Aluminum Corp. of China Amid Strong Q1 Performance and Promising Growth Strategies | |||
| Asymchem Laboratories (Tianjin) Co., Ltd. Class H | BUY HK$90.12→HK$83.94 | ― | -16.90% | Reiterated | Asymchem (6821:HK) PT Lowered to HK$83.94 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Asymchem (6821:HK) to HK$83.94 (from HK$90.12) while maintaining a Buy rating. | |||
| JD.com, Inc. Class A | BUY HK$145 | ― | -11.50% | Initiated | Goldman Sachs Reinstates JD.Com (H-Shares) (9618:HK) (JD) at BuyGoldman Sachs analyst Ronald Keung reinstates coverage on JD.Com (H-Shares) (9618:HK) (NASDAQ: JD) with a Buy rating and a price target of HK$145.00. | |||
| JD Logistics, Inc. | BUY HK$12 | ― | -11.50% | Initiated | Goldman Sachs Reinstates JD Logistics Inc (2618:HK) (JDLGF) at BuyGoldman Sachs analyst Ronald Keung reinstates coverage on JD Logistics Inc (2618:HK) (OTC: JDLGF) with a Buy rating and a price target of HK$12.00. | |||
| Galaxy Entertainment Group | BUY HK$56.6→HK$50.2 | ― | -0.80% | Reiterated | Galaxy Entertainment Group Ltd (27:HK) (GXYEF) PT Lowered to HK$50.20 at Goldman SachsGoldman Sachs analyst Simon Cheung lowered the price target on Galaxy Entertainment Group Ltd (27:HK) (OTC: GXYEF) to HK$50.20 (from HK$56.60) while maintaining a Buy rating. | |||
Phyllis WangUBS Not Ranked | Zhuzhou CRRC Times Electric Co | BUY HK$36.1→HK$39.4 | ― | ― | Reiterated | Zhuzhou CRRC Times Electric Co., Ltd (3898:HK) (ZHUZY) PT Raised to HK$39.40 at UBSUBS analyst Phyllis Wang raised the price target on Zhuzhou CRRC Times Electric Co., Ltd (3898:HK) (OTC: ZHUZY) to HK$39.40 (from HK$36.10) while maintaining a Buy rating. | |||
Ken LiuUBS Not Ranked | China Longyuan Power Group | HOLD HK$6→HK$5.9 | ― | ― | Reiterated | China Longyuan Power Group Corp (916:HK) (CLPXF) PT Lowered to HK$5.90 at UBSUBS analyst Ken Liu lowered the price target on China Longyuan Power Group Corp (916:HK) (OTC: CLPXF) to HK$5.90 (from HK$6.00) while maintaining a Neutral rating. | |||
| Akeso, Inc. | HOLD HK$50→HK$54 | ― | -22.50% | Assigned | ||||
| Innovent Biologics | BUY HK$54→HK$47 | ― | -22.50% | Assigned | Innovent Biologics (IVBXF) Receives a Buy from Bernstein | |||
| Hong Kong Exchanges & Clearing | BUY HK$322.28→HK$324.31 | ― | -1.20% | Reiterated | Hong Kong Exchange (388:HK) (HKXCY) PT Raised to HK$324.31 at Nomura/InstinetNomura/Instinet analyst Shengbo Tang raised the price target on Hong Kong Exchange (388:HK) (OTC: HKXCY) to HK$324.31 (from HK$322.28) while maintaining a Buy rating. | |||
| ASM Pacific Technology | HOLD HK$78→HK$106 | ― | -2.70% | Reiterated | ASM Pacific Technology (522:HK) (ASMVF) PT Raised to HK$106 at HSBCHSBC analyst Wern Juan Chng raised the price target on ASM Pacific Technology (522:HK) (OTC: ASMVF) to HK$106.00 (from HK$78.00) while maintaining a Hold rating. | |||
| Prada SpA | BUY HK$67→HK$70 | ― | -1.80% | Reiterated | Prada SpA (1913:HK) (PRDSY) PT Raised to HK$70 at MacquarieMacquarie analyst Linda Huang raised the price target on Prada SpA (1913:HK) (OTC: PRDSY) to HK$70.00 (from HK$67.00) while maintaining a Outperform rating. | |||
| Xiaomi | BUY HK$29.39→HK$31.24 | ― | -0.90% | Reiterated | Xiaomi Corp (1810:HK) (XIACY) PT Raised to HK$31.24 at MacquarieMacquarie analyst Eugene Hsiao raised the price target on Xiaomi Corp (1810:HK) (OTC: XIACY) to HK$31.24 (from HK$29.39) while maintaining a Outperform rating. | |||
| Great Wall Motor Co | BUY HK$13→HK$14 | ― | -13.90% | Reiterated | Buy Rating for Great Wall Motor Co. Amid Strong Q1 Profits and Promising EV Outlook | |||
| Ping An Insurance Company of China | BUY HK$52 | ― | -8.30% | Reiterated | Strong Performance and Growth Potential Underpin Buy Rating for Ping An Insurance | |||
 | CNOOC Limited | BUY HK$21 | ― | 0.10% | Reiterated | ||||
| Ping An Insurance Company of China | BUY HK$54.12→HK$54.41 | ― | -1.20% | Reiterated | Ping An Insurance Company of China (PIAIF) Receives a Buy from Nomura | |||
| Pop Mart International Group Limited | SELL HK$19→HK$31 | ― | -10.80% | Reiterated | Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Kering SA (LSE: GB:0IIH), Pop Mart International Group Limited (Frankfurt: DE:735) and Scandic Hotels Group AB (Frankfurt: DE:10H) | |||
 | Ping An Insurance Company of China | BUY HK$46→HK$42 | ― | -12.70% | Reiterated | Ping An Insurance (2318:HK) (PNGAY) PT Lowered to HK$42 at HSBCHSBC analyst Kailesh Mistry lowered the price target on Ping An Insurance (2318:HK) (OTC: PNGAY) to HK$42.00 (from HK$46.00) while maintaining a Buy rating. | |||
| Li Ning Company | BUY HK$24.86→HK$22.17 | ― | -4.10% | Reiterated | Maintaining Buy on Li Ning: Promising 2024 Outlook and Attractive Valuation |
Rows: